GABRB1

Chr 4AD

gamma-aminobutyric acid type A receptor subunit beta1

Also known as: DEE45, EIEE45

The gamma-aminobutyric acid (GABA) A receptor is a multisubunit chloride channel that mediates the fastest inhibitory synaptic transmission in the central nervous system. This gene encodes GABA A receptor, beta 1 subunit. It is mapped to chromosome 4p12 in a cluster comprised of genes encoding alpha 4, alpha 2 and gamma 1 subunits of the GABA A receptor. Alteration of this gene is implicated in the pathogenetics of schizophrenia. [provided by RefSeq, Jul 2008]

OMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 0.311 OMIM phenotype
Clinical SummaryGABRB1
🧬
Gene-Disease Validity (ClinGen)
genetic developmental and epileptic encephalopathy · ADLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.98). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
5 unique Pathogenic / Likely Pathogenic· 218 VUS of 448 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.31LOEUF
pLI 0.981
Z-score 4.11
OE 0.12 (0.050.31)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
2.65Z-score
OE missense 0.55 (0.490.63)
156 obs / 281.1 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.12 (0.050.31)
00.351.4
Missense OE?0.55 (0.490.63)
00.61.4
Synonymous OE?1.12
01.21.6
LoF obs/exp: 3 / 25.3Missense obs/exp: 156 / 281.1Syn Z: -1.00

This gene — mechanism propensity

DN
0.6840th %ile
GOF
0.74top 25%
LOF
0.4726th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function, gain-of-function and dominant-negative). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFLOEUF 0.31
GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

448 submitted variants in ClinVar

Classification Summary

Pathogenic1
Likely Pathogenic4
VUS218
Likely Benign194
Benign24
Conflicting5
1
Pathogenic
4
Likely Pathogenic
218
VUS
194
Likely Benign
24
Benign
5
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
1
0
0
1
Likely Pathogenic
0
4
0
0
4
VUS
13
191
13
1
218
Likely Benign
0
2
83
109
194
Benign
0
1
12
11
24
Conflicting
5
Total13199108121446

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

19 pathogenic / likely-pathogenic (of 24) ClinVar copy-number / structural variants overlap GABRB1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

GABRB1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →